Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Jane Kendrew"'
Autor:
Emily Wright, Stewart Brown, Lorraine Mooney, Charlotte Bell, Nick Moore, Theoni Katopodi, Yin Xin Ho, Lyndsey Hanson, Amy Cantrell, Jane Kendrew
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/2723f0d6443a40869da7d8e3ca4fd4dd
Autor:
Emily Wright, Stewart Brown, Lorraine Mooney, Charlotte Bell, Nick Moore, Theoni Katopodi, Yin Xin Ho, Lyndsey Hanson, Amy Cantrell, Jane Kendrew, Pablo Binder, Tobias Bunday, Paul Farrington, Shannon Sharman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/04843d98fa6b46d29dbefe7fe5341d13
Autor:
Simon T. Barry, Stephen R. Wedge, Masabumi Shibuya, Juliane M. Jürgensmeier, Donald J. Ogilvie, Laurent Hennequin, Charles L. Farnsworth, Jeffrey C. Silva, Claire Barnes, Sian Taylor, Graham Sproat, Nicola Broadbent, Philippa Dudley, Jane Kendrew, Anna Wainwright, Sue Ashton, Neil H. James, Zena Wilson, Kirsty Ratcliffe, Sandra R. Brave
Supplementary Tables 1-3 from Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b81f7c3e475189f7807aec38b527252
https://doi.org/10.1158/1535-7163.22496458.v1
https://doi.org/10.1158/1535-7163.22496458.v1
Autor:
Simon T. Barry, Stephen R. Wedge, Masabumi Shibuya, Juliane M. Jürgensmeier, Donald J. Ogilvie, Laurent Hennequin, Charles L. Farnsworth, Jeffrey C. Silva, Claire Barnes, Sian Taylor, Graham Sproat, Nicola Broadbent, Philippa Dudley, Jane Kendrew, Anna Wainwright, Sue Ashton, Neil H. James, Zena Wilson, Kirsty Ratcliffe, Sandra R. Brave
Supplementary Figure 1 from Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e3cd5c5600a7c3ff0d61470189a4156
https://doi.org/10.1158/1535-7163.22496464
https://doi.org/10.1158/1535-7163.22496464
Autor:
Simon T. Barry, Stephen R. Wedge, Masabumi Shibuya, Juliane M. Jürgensmeier, Donald J. Ogilvie, Laurent Hennequin, Charles L. Farnsworth, Jeffrey C. Silva, Claire Barnes, Sian Taylor, Graham Sproat, Nicola Broadbent, Philippa Dudley, Jane Kendrew, Anna Wainwright, Sue Ashton, Neil H. James, Zena Wilson, Kirsty Ratcliffe, Sandra R. Brave
Cediranib is a potent inhibitor of the VEGF receptor (VEGFR)-2 and VEGFR-3 tyrosine kinases. This study assessed the activity of cediranib against the VEGFR-1 tyrosine kinase and the platelet-derived growth factor receptor (PDGFR)-associated kinases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c66c6430c693a5c3aeeab117ab20e0f
https://doi.org/10.1158/1535-7163.c.6535279
https://doi.org/10.1158/1535-7163.c.6535279
Autor:
Simon T. Barry, Stephen R. Wedge, Masabumi Shibuya, Juliane M. Jürgensmeier, Donald J. Ogilvie, Laurent Hennequin, Charles L. Farnsworth, Jeffrey C. Silva, Claire Barnes, Sian Taylor, Graham Sproat, Nicola Broadbent, Philippa Dudley, Jane Kendrew, Anna Wainwright, Sue Ashton, Neil H. James, Zena Wilson, Kirsty Ratcliffe, Sandra R. Brave
Supplementary Figure Legend from Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::908f9c406205b7374b4c5f4dca4484fd
https://doi.org/10.1158/1535-7163.22496461
https://doi.org/10.1158/1535-7163.22496461
Autor:
Simon T. Barry, Vahe Bedian, David C. Blakey, Hazel M. Weir, Neil R. Smith, Dawn Baker, Li Peng, Melissa Damschroder, Song Cho, Philip Petteruti, Jane Kendrew, Cath Eberlein, Kathy Manchulenko, Brandon C. Clavette, Ian N. Foltz, Margaret Veldman-Jones, Sarah Ross, David W. Jenkins
PDF file - 153K, Figure to support screening for antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82f789567bdbe38aa8242ddaae517a98
https://doi.org/10.1158/1535-7163.22497729.v1
https://doi.org/10.1158/1535-7163.22497729.v1
Autor:
Simon T. Barry, Vahe Bedian, David C. Blakey, Hazel M. Weir, Neil R. Smith, Dawn Baker, Li Peng, Melissa Damschroder, Song Cho, Philip Petteruti, Jane Kendrew, Cath Eberlein, Kathy Manchulenko, Brandon C. Clavette, Ian N. Foltz, Margaret Veldman-Jones, Sarah Ross, David W. Jenkins
PDF file - 98K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f07ae0e482808c3b8eacc87796d9ded
https://doi.org/10.1158/1535-7163.22497726.v1
https://doi.org/10.1158/1535-7163.22497726.v1
Autor:
Simon T. Barry, Vahe Bedian, David C. Blakey, Hazel M. Weir, Neil R. Smith, Dawn Baker, Li Peng, Melissa Damschroder, Song Cho, Philip Petteruti, Jane Kendrew, Cath Eberlein, Kathy Manchulenko, Brandon C. Clavette, Ian N. Foltz, Margaret Veldman-Jones, Sarah Ross, David W. Jenkins
The Notch signaling pathway has been implicated in cell fate determination and differentiation in many tissues. Accumulating evidence points toward a pivotal role in blood vessel formation, and the importance of the Delta-like ligand (Dll) 4-Notch1 l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d542fb2b425861aad9c75220d50b1b
https://doi.org/10.1158/1535-7163.c.6535701.v1
https://doi.org/10.1158/1535-7163.c.6535701.v1
Autor:
Simon T. Barry, Stephen R. Wedge, Chris Womack, Jane Kendrew, Karen McDaid, Sunita Mistry, Xin Wang, Ruth Swann, Aurelien Pommier, Matthew Farren, Dawn Baker, Neil R. Smith
PDF file - 2029K, Examples of tumour types classified as predominantly tumour vessel or stromal vessel phenotypes from TMA cores.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d5814d3b237cedd9590ddb72d713056
https://doi.org/10.1158/1078-0432.22445714
https://doi.org/10.1158/1078-0432.22445714